NAT Diagnostics Overview

  • Founded
  • 2014

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees
  • Latest Deal Type
  • M&A

NAT Diagnostics General Information

Description

Developer of a molecular diagnostic platform designed to provide true Point-of-Care testing for infectious disease. The company's platform uses a technology that is based on a novel isothermal nucleic acid amplification and detection method that requires only ten minutes, enabling physicians' offices, clinics and pharmacies to offer Point-of-Care testing results which are highly accurate and costs low.

Contact Information

Website
www.natdx.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Services
Primary Office
  • 11585 Sorrento Valley Road
  • Suite 107
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NAT Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 15-May-2020 00.000 Completed Generating Revenue
2. Seed Round 16-Nov-2017 00.00 00.000 Completed Startup
1. Seed Round 11-Sep-2015 $2.91M $2.91M Completed Startup
To view NAT Diagnostics’s complete valuation and funding history, request access »

NAT Diagnostics Patents

NAT Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017247133-A1 Isothermal amplification components and processes Pending 04-Apr-2016 0000000000
US-9617587-B1 Isothermal amplification components and processes Active 04-Apr-2016 0000000000
US-20220064703-A1 Isothermal amplification components and processes Pending 04-Apr-2016 0000000000
US-11118219-B2 Isothermal amplification components and processes Active 04-Apr-2016 0000000000
US-20200332340-A1 Isothermal amplification components and processes Active 04-Apr-2016 C12Q1/6844
To view NAT Diagnostics’s complete patent history, request access »

NAT Diagnostics Executive Team (1)

Name Title Board Seat Contact Info
Andrew Miller Ph.D Chief Executive Officer & Founder
To view NAT Diagnostics’s complete executive team members history, request access »

NAT Diagnostics Board Members (3)

Name Representing Role Since
Allan Fan NAT Diagnostics Board Member 000 0000
David Galas NAT Diagnostics Board Member 000 0000
Thomas Wu NAT Diagnostics Board Member 000 0000
To view NAT Diagnostics’s complete board members history, request access »

NAT Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial